The US Drug Enforcement Agency (DEA) plans to move marijuana from Schedule I to Schedule III under the Controlled Substance Act. This change comes after the US Food and Drug Administration’s 2023 determination that marijuana has medical use. The process involves a formal rule submission and public comment before potential impacts on patients, researchers, and the cannabis industry.
Read the full story here
Written by:
Published on May 3, 2024 at 06:41AM
Source: Medscape Internal Medicine Headlines (opens in new tab)